P402. A novel high-dose mesalazine tablet is as effective as conventional low-dose mesalazine tablets in inducing remission in patients with mildly to moderately active ulcerative colitis (UC): A double-blind, double-dummy, multicentre, randomised trial

Autor:	Andrey E. Dorofeyev, Jacek Artur Romatowski, Axel Dignaß, Roland Greinwald, Jeļena Derova, Tanju Nacak, Vladimir Vasilievich Pavlenko, Laimas Virginijus Jonaitis, Robert Schnabel
Rok vydání:	2016
Předmět:	medicine.medical_specialty business.industry Low dose Gastroenterology General Medicine medicine.disease Ulcerative colitis Double blind chemistry.chemical_compound Pharmacotherapy Mesalazine chemistry Internal medicine Medicine In patient business
Zdroj:	Journal of Crohn's and Colitis. 10:S301.1-S301
ISSN:	1876-4479 1873-9946
DOI:	10.1093/ecco-jcc/jjw019.521
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c3c3ba2af54f6c00beea4deea4a2c33f https://doi.org/10.1093/ecco-jcc/jjw019.521 Zobrazit plný text záznamu